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Background: Premenstrual syndrome (PMS) occurs in women during their reproductive age with a quite negative
impact on their daily lives. Women with PMS experience a wide range of physical or psychological symptoms and
seek treatment for them. Chinese herb medicine (CHM) is commonly used for PMS and the goal of this study is to
investigate the prescription patterns of CHM for PMS by using a nationwide database.
Methods: Prescriptions of CHM were obtained from two million beneficiaries randomly sampled from the National
Health Insurance Research Database, a nationwide database in Taiwan. The ICD-9 code 625.4 was used to identify
patients with PMS. Association rule mining and social network analysis were used to explore both the combinations
and the core treatments for PMS.
Results: During 1998-2011, a total of 14,312 CHM prescriptions for PMS were provided. Jia-Wei-Xiao-Yao-San
(JWXYS) was the CHM which had the highest prevalence (37.5% of all prescriptions) and also the core of
prescription network for PMS. For combination of two CHM, JWXYS with Cyperus rotundus L. was prescribed most
frequently, 7.7% of all prescriptions, followed by JWXYS with Leonurus heterophyllus Sweet, 5.9%, and Cyperus
rotundus L. with Leonurus heterophyllus Sweet, 5.6%.
Conclusions: JWXYS-centered CHM combinations were most commonly prescribed for PMS. To the best of our
knowledge, this is the first pharmaco-epidemiological study to review CHM treatments for PMS. However, the
efficacy and safety of these commonly used CHM were still lacking. The results of this study provide valuable
references for further clinical trials and bench studies.
Keywords: Chinese herbal medicine, Premenstrual syndrome, Association rule mining, National health insurance
research database, Social network analysis, Traditional Chinese medicineBackground
Premenstrual syndrome (PMS) is a common gynecological
disease among women in reproductive age. Most women
experienced one or more physical, psychological or behav-
ioral symptoms preceding or during menses; for some
women, these symptoms severely disrupt their normal life
[1]. The prevalence of PMS is high due to the various
symptoms of PMS, such as food cravings, abdominal* Correspondence: yuchn.chen@googlemail.com
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unless otherwise stated.discomfort, headache, pain, depression, irritability and anx-
iety [2]. Around 75% of reproductive age women have mild
symptoms and 20-30% of women have clinically significant
PMS symptoms [3,4]. Additionally, 13-18% of women need
treatment due to Premenstrual Dysphoric Disorder (PMDD),
the severe form of PMS [5].
PMS symptoms have been attributed to fluctuations in
levels of neurotransmitters in the central nervous system
and/or cyclic hormonal changes. Central nervous system
neurotransmitters such as serotonin (5-hydroxytryptamine)
and γ-aminobutyric acid (GABA) appear to contribute to
the pathogenesis of PMS [6-9]. Moreover, dynamic fluctua-
tions in estradiol or progesterone in the late luteal phasetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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symptoms [10,11]. Accordingly, selective serotonin re-
uptake inhibitors (SSRIs) are the mainstay treatment of
PMS, and hormone therapy to suppress ovulation is often
used as well. In addition, other psychoactive drugs, such
as alprazolam or buspirone, have been used for PMS with
less effect [8,12].
These pharmacologic approaches are associated with
side effects that obviously concern women with PMS. As
a result, compliance in women with PMS treated with
SSRIs is rather poor due to adverse drug effects, such as
headache, weight gain, drowsiness, sexual dysfunction,
and insomnia [13,14]. As well, prescriptions of alprazo-
lam are limited due to drug dependence, intolerance or
even abuse [8]. For these reasons, various types of trad-
itional Chinese medicine (TCM) treatments, including
acupuncture and Chinese herbal medicine (CHM), are
used by women as an integrative approach to PMS
[15-17]. Although TCM use is increasing yearly, infor-
mation about CHM prescriptions used for women with
PMS is still lacking [18].
CHM prescriptions are part of a rather complicated
system and every prescription is made according to each
patient’s TCM syndrome, or “Zheng” in Chinese, which
is an overall summary of each patient’s physical signs or
symptoms. Different diseases have their specific prepon-
derance of TCM syndrome and the TCM syndrome varies
from patient to patient [19]. Based on individuals’ diseases
and TCM syndrome, different core treatments are pre-
scribed and therefore it is feasible to discover the most
important CHM and TCM understanding about a disease
[20-22]. These findings are keys to further studies, espe-
cially new drug discovery, from the viewpoint of TCM
system biology [23]. Application of association rule mining
(ARM) and social network analysis (SNA) on a huge pre-
scription database is a practical method for exploration of
CHM core treatments and combinations, and several core
treatments were successfully discovered in menopausal
syndrome [24], primary dysmenorrhea [20], urticaria [21]
and asthma [22].
The National Health Insurance Research Database
(NHIRD), a nationwide health insurance claims database
in Taiwan, is a comprehensive population-based tool
that helpful to analyze the CHM prescription patterns
[20-22,24]. The NHIRD is composed of all medical records,
including ambulatory visits and hospitalization, reimbursed
by the National Health Insurance (NHI) since 1995 [25].
Additionally, the NHI is unique in Taiwan, because both
traditional Chinese medicine (CHM) and western medicine
are equally reimbursed. Therefore, the option of using
TCM or western medicine is completely unrestricted and
largely dependent on the patient’s preference or habits.
The quality in reimbursement is crucial to eliminate the
bias on intervention selection. By using the NHIRD, theresults of analysis on prescription patterns can be regar-
ded as a consensus made by TCM doctors in Taiwan due
to high coverage of the NHI, with over 99% of all Taiwanese
population enrolled in the system [21,24].
We hypothesized that there should be core CHM
treatment for PMS and this study aimed at discover-
ing the core treatment patterns by applying ARM and
SNA on the nationwide database. In addition to bet-
ter understanding the viewpoint of TCM on PMS,
further studies regarding efficacy, safety and mechanisms
of action could be conducted based on the results of
this work.Methods
Data source
The NHIRD was used to obtain CHM prescriptions associ-
ated with the diagnosis of PMS. Two million individuals
randomly sampled from the NHIRD and all medical claims
of these individuals between 1998 and 2011 were extracted.
This sample dataset is representative of the entire eligible
Taiwanese population since no gender or age differences
between sample and entire database were reported. The
medical information contained in the NHIRD included
patient’s birth date, gender, visit date, hospitalization date,
medical services providers, treatments, managements, and
the reasons for visits or hospitalization. The International
Classification of Disease 9th revision code (ICD-9) was used
to identify the indications for medical services. Doctors
may use up to three ICD-9 codes for every ambulatory visit
and the first diagnosis was required to be the main reason
for each visit. All TCM managements, including CHM,
acupuncture and massage, were included.Study subjects
To recognize the PMS patients, ICD-9 code 625.4
(Premenstrual tension syndromes) was used and subject
selection was performed by Chen YC and Chen HY, inde-
pendently. PMS was characterized by periodical affective
and somatic disorders, and it was associated with various
symptoms [26,27]. Other mood disorders or menstrual
diseases should be excluded, such as dysmenorrhea, endo-
metriosis, or perimenopausal diseases, to make a de-
finitive diagnosis; therefore, ambulatory visits with any
diagnosis other than PMS were excluded. Addition-
ally, only visits with a single diagnosis of PMS were
included to reduce the influence of co-morbidities
since TCM doctors usually treat patients by modifying
a patients’ physical condition and by trying to treat all co-
morbidities at once. Also, to eliminate the potential influ-
ence on choosing CHM, TCM visits with acupuncture
and massage were excluded since these TCM modalities
were thought to be adjuvant of CHM and may influence
CHM prescription.
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Frequencies, durations and dosage of CHM contained in
prescriptions were the primary variables in this study to
identify single agents and combinations of CHM com-
monly used for PMS. Two types of CHM are reimbursed
by the NHI, single herb (SH) and herbal formula (HF),
which follow fixed proportions of SH according to TCM
classics. Quality control of CHM is assured as SH and
HF are all produced as concentrated powders by Good
Manufacturing Practice (GMP) pharmaceutical factories.
In clinical practice, TCM doctor usually use several HF
and/or SH in one prescription according to patient’s
disease, TCM syndrome and associated symptoms. HF
in prescriptions often serves as the core treatment for a
disease and thus it is usually co-prescribed with other
CHM according to TCM principles behind preparing
prescriptions. The relationships between various CHM
are typically quite complicated and a CHM network is
commonly used to demonstrate the prescription patterns
of CHM [20,28]. The frequency of connections among
CHM is also assessed to verify the role of each CHM
among network.
Statistical analysis
Descriptive statistics were used to explore the prescription
patterns of CHM for PMS. The prescription frequency,
presented as prevalence, of the most commonly used
CHM and their combinations, was analyzed. Moreover, the
efficacy and potential underlying mechanisms of the com-
monly used CHM were thoroughly searched and re-
viewed. The English, Latin, Chinese names or corresponding
Kampo medicine names were used in combination with
“premenstrual syndrome” or “premenstrual dysphoric dis-
order” as the key words in searching references. Pubmed
and Medline were both used as the target databases and
the last assessed date was March 13, 2014. Chen HY, Lin
YH, Yang SH and Chen JL were responsible for reviewing
the searched references and determined the mechanisms
of each listed CHM.
To explore the combinations of CHM, ARM and SNA
were applied to illustrate the relationships between com-
monly used CHM. ARM is a statistical model widely used
in medical research to examine associations between
drugs or disease conditions, such as CHM prescription
patterns for menopausal syndrome and analysis on co-
morbidities of a disease [24,29]. Support and confidence
factors are two key factors used in the ARM model to
filter the significant associations among all CHM. Support
factor was the prevalence of CHM combinations and con-
fidence factor was similar to the conditional probability of
a certain combination. For example, among two CHM,
named CHM A and CHM B, support factor was presented
as the probability (CHM A ∩ CHM B) and confidence fac-
tor was presented as the probability (CHM A ∩ CHM B)/probability (CHM A); only if both support and confidence
factor were higher than the pre-set threshold was the
association “CHM A with CHM B” considered significant.
Significant associations were interpreted as “if CHM A
was prescribed, CHM B was commonly used as well as an
adjuvant”. Software R, version 2.15, and its statistical pack-
age “arule” was used to apply ARM model in this study.
The threshold for support and confidence factors were set
to 1% and 30%, and the threshold selected resulted from
consensus among all co-authors of this work. The free-
ware NodeXL of SNA (http://nodexl.codeplex.com/) was
used to illustrate the associations between commonly used
CHM for PMS.
Results
Demographic characteristics of TCM users
Among two million representative dataset, a total of
5,668 patients were identified as having visited TCM
doctors for PMS. During 1998-2011, a total of 14,312
visits were made by TCM visitors, and CHM was the
most commonly used modality of TCM, accounting for
96.6% of all visits (13,820 visits). Additionally, TCM doc-
tors commonly prescribed multiple CHM concomitantly;
5.4 CHM, including SH and/or HF, were used in on aver-
age in one prescription. Additionally, CHM was usually
prescribed three times a day (89.0% of all prescriptions),
followed by four times a day (8.4%).
The most commonly used HF and SH
Among all prescriptions, Jia-Wei-Xiao-Yao-San (JWXYS)
was the most commonly used CHM, accounting for 37.5%
of all prescriptions, and it was also the most commonly
used HF, followed by Dang-Gui-Shao-Yao-San (DGSYS)
(2,064/14.9%) and Gui-Zhi-Fu-Ling-Wan (1,245/9.0%)
(Table 1). Among single herbs, Cyperus rotundus L.
was prescribed most frequently (2,485/18.0%), followed by
Leonurus heterophyllus Sweet (2,097/15.2%) and Corydalis
yanhusuo W. T. Wang (1,573/11.4%) (Table 2). Interest-
ingly, although SH were usually used as an adjuvant
to HF, Cyperus rotundus L. and Leonurus heterophyllus
Sweet, both SH, were prescribed even more frequently
than the HF DGSYS in this population. Moreover, the
dose of commonly used HF was 2-3 times higher than SH,
at approximately 4 gm/day versus less than 1.4 gm/day.
(Tables 2 and 3).
Two CHM in combinations for PMS
JWXYS prescribed with Cyperus rotundus L. was the most
frequently used two-CHM combination, accounting for
7.7% of all prescriptions (Table 3). JWXYS with Leonurus
heterophyllus Sweet (818/5.9%) and Cyperus rotundus
L. with Leonurus heterophyllus Sweet (773/5.6%) were
the second and third the most frequently prescribed
combinations. “HF with SH” were the most often used
Table 1 The top five most commonly used herbal formulas for premenstrual syndrome (N = 13,820)










Paeonia lactiflora Pall., Bupleurum chinense DC. DC.,
Atractylodes macrocephala Koidz., Poria cocos (Schw.)
Wolf, Angelica sinensis (Oliv.) Diels., Mentha haplocalyx
Briq., Glycyrrhiza uralensis Fisch., Zingiber officinale Rosc.,
Paeonia suffruticosa Andr., and Gardenia jasminoides Ellis.




5,185 4.87 6.4 37.5
Dang-Gui-Shao-
Yao-San
Angelica sinensis (Oliv.) Diels., Ligusticum chuanxiong Hort.,
Paeonia lactiflora Pall., Atractylodes macrocephala Koidz.,
Poria cocos (Schw.) Wolf, and Alisma plantago-aquatica




2,064 4.34 6.4 14.9
Gui-Zhi-Fu-Ling-
Wan
Cinnamomum cassia Blume, Poria cocos (Schw.) Wolf,
Paeonia lactiflora Pall., Paeonia suffruticosa Andr., and
Prunus persica (L.) Batsch (or Prunus davidiana (Carr.)
Franch.)
Blood stasis 1,245 3.87 6.3 9.0
Wen-Jing-Tang Evodia rutaecarpa (Juss.) Benth., (or Evodia rutaecarpa
(Juss.) Benth. var. officinalis (Dode) Huang, Evodia
rutaecarpa (Juss.) Benth. var. bodinieri (Dode) Huang),
Cinnamomum cassia Blume, Angelica sinensis (Oliv.) Diels.,
Paeonia lactiflora Pall., Ligusticum chuanxiong Hort., Panax
ginseng C. A. Meyer, Glycyrrhiza uralensis Fisch., Equus
asinus L., Ophiopogon japonicus Ker-Gawl., Pinellia ternata
(Thunb.) Breit, and Zingiber officinale Rosc.
Blood stasis and
deficient cold
1,120 4.25 6.3 8.1
Shao-Fu-Zhu-
Yu-Tang
Foeniculum vulgare Mill., Zingiber officinale Rosc.,
Cinnamomum cassia Blume, Angelica sinensis (Oliv.)
Diels., Ligusticum chuanxiong Hort., Paeonia lactiflora
Pall. or Peaonia veitchii Lynch, Trogopterus xanthipes
Milne-Edwards or Pteromys volans L.
Qi stagnation and
blood stasis
994 3.97 6.2 7.2
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cept in TCM.
Core treatment for PMS
JWXYS was the core treatment for PMS because it
accounted for the highest prevalence among all CHM
and 80% of the most commonly used two-CHM combi-
nations. Additionally, the central role of JWXYS can be
found in the network of commonly used CHM (Figure 1).
Other CHM scattered peripherally represented their
adjuvant action of PMS.Table 2 The top ten most commonly used single herb for pre
Latin name Indication of T
Cyperus rotundus L. Qi stagnation in
Leonurus heterophyllus Sweet Blood stasis
Corydalis yanhusuo W. T. Wang Qi stagnation an
Salvia miltiorrhiza Bge. Blood stasis
Eucommia ulmoides Oliv. Kidney and liver
Scutellaria baicalensis Georgi Dampness-heat
Dipsacus asperoides C. Y. Cheng at T. M. Ai Blood stasis
Cuscuta chinensis Lam., or Cuscuta japonica Choisy Kidney yang and
Pueraria lobata (Willd.) Ohwi or Pueraria thomsonii Benth. External wind, fl
Paeonia suffruticosa Andr. Blood stasis andDiscussion
The key finding of this study is that JWXYS was the core
treatment for PMS and certain CHM, such as Cyperus
rotundus L. and Leonurus heterophyllus Sweet, were
frequently prescribed with JWXYS. This is the first
pharmaco-epidemiological study about CHM for PMS.
Among all CHM used for PMS, only JWXYS was exam-
ined for its efficacy and included in systematic review
[15,17]. The effectiveness and safety of other commonly
used CHM, especially when they are combined with
JWXYS, have not been studied yet, and CHM included inmenstrual syndrome (N = 13,820)






liver 2,485 1.38 6.3 18.0
2,097 1.33 6.3 15.2
d blood stasis 1,573 1.28 6.2 11.4
1,281 1.30 6.4 9.3
deficiency 1,023 1.26 6.3 7.4
858 1.30 6.5 6.2
644 1.17 6.4 4.7
yin deficiency 639 1.44 6.6 4.6
uid deficiency 616 1.33 6.4 4.5
heat 605 1.43 6.6 4.4
Table 3 The top ten most commonly used two-herb combinations of Chinese herbal medicine (CHM) for premenstrual
syndrome (N = 13,820)
CHM A CHM B Instances Prevalence (%)
JWXYS with Cyperus rotundus L. 1,059 7.7
JWXYS with Leonurus heterophyllus Sweet 818 5.9
Cyperus rotundus L. with Leonurus heterophyllus Sweet 773 5.6
JWXYS with Corydalis yanhusuo W. T. Wang 564 4.1
Cyperus rotundus L. with Corydalis yanhusuo W. T. Wang 512 3.7
JWXYS with Salvia miltiorrhiza Bge. 467 3.4
Cyperus rotundus L. with Salvia miltiorrhiza Bge. 377 2.7
JWXYS with Gui-Zhi-Fu-Ling-Wan 375 2.7
JWXYS with Scutellaria baicalensis Georgi 262 1.9
JWXYS with Curcuma longa L. or Curcuma aromatica Salisb. 251 1.8
Chen et al. BMC Complementary and Alternative Medicine 2014, 14:206 Page 5 of 9
http://www.biomedcentral.com/1472-6882/14/206latest systematic review are not exactly commonly used in
daily practice [17]. The results of this study provide ideal
candidate for further studies as we strive to achieve the
goal of establishing evidence-based medicine viewpoints
on CHM.
JWXYS has been reported to have anxiolytic and anti-
depression effects in animal models although its effective-
ness on PMS remains unclear (Table 4). From TCM’sFigure 1 Social network analysis on associations between commonly
GZFLW: Gui-Zhi-Fu-Ling-Wan. *JWXYS was the center of the CHM network
circle represents higher prevalence, and thicker connection line representsviewpoint, JWXYS, which was developed about a thou-
sand years ago in the TCM classic of prescriptions, is used
to treat liver and spleen blood deficiency with heat trans-
forming, which fairly represents mood disorder, gastro-
intestinal dysfunction and menstrual problems due to
endocrine disorder. Therefore, it is frequently used to treat
primary dysmenorrhea [20], menopausal syndrome [24],
depression [30] and functional dyspepsia [31]. The high*
used CHM (top 10). Abbreviations: JWXYS: Jia-Wei-Xiao-Yao-San;
prescribed for PMS and became the core treatment for PMS. **Larger
more common combination.
Table 4 Possible pharmacological mechanisms of Chinese herbal medicine (CHM) used for premenstrual syndrome
Name Ingredients Possible mechanisms of extract of SH
Single herb (SH)
Cyperus rotundus L. Hydroalcoholic extract Anti-oxidative effect [33]
Essential oil Anti-oxidative effect [34]
Leonurus heterophyllus Sweet Methanol extract Anti-oxidative effect [35]
Corydalis yanhusuo W. T. Wang Tetrahydropalmatine Anxiolytic effect [36]
Analgesic effect [37]
Salvia miltiorrhiza Bge. Miltirone Anxiolytic effect [38]
Salvianolic acid B Anti-depressant effect [39]
Analgesic effect [40]
Anti-oxidative effect [41]
Tanshinone IIA Analgesic effect [42]
Eucommia ulmoides Oliv. Water extract Anti-oxidative effect [43,44]
Herbal formula (HF)
Jia-Wei-Xiao-Yao-San (JWSYS) Anti-depressant effect on animal model [45,46]
IL-6 related anti-depressant effect on menopausal women with mood disorder [47]
Anxiolytic effect on animal model [48]
Reduced proinflammatory cytokine [49]
Dang-Gui-Shao-Yao-San Anti-depressant effect on animal model [50]
Anti-oxidative effect in vitro [51]
Wen-Jing-Tang Anti-depressant effect for menopausal women [52]
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tinal problems among PMS women in Taiwan may be the
reason for the leading role of JWXYS in all CHM [32].
In addition to this core treatment, several CHM were
found to be significantly associated with core treatments,
and thus a network of CHM prescribed for PMS can be
established (Figure 1). These combinations of CHM
were valuable guides for clinical practice since TCM
doctors usually use several CHM in one prescription
(5.4 CHM on average). This finding was expected as it
has its foundation in TCM teachings and with potential
pharmacological effects of CHM, CHM prescriptions are
made according to an individual’s constitution, namely
bian-zheng-lun-zhi, which means the identification of
TCM syndrome and treatment. It is reasonable since
human physiology is complex and multiple strategies to
treat PMS may be needed. Interestingly, anti-oxidative
effects are reported extensively among the CHM surround-
ing JWXYS [33,35,41,43], which may complement JWXYS
since JWXYS lacks anti-oxidative effect. The anti-oxidative
effects exclusively found in SH strongly imply the import-
ance of oxidative stress on PMS, such as Cyperus rotundus
L. and Leonurus heterophyllus Sweet (Table 4). To date,
only one study based on 41 patients discussed the po-
tential association between PMS and this imbalance
of oxidants/anti-oxidants [53]. Thus, the essential role
of anti-oxidation therapy for PMS will require furtherstudies in order to be defined properly. This finding
represents the merit of using ARM and social network
analysis to analyze the relations between CHM, and not
just focusing on the use of a single CHM.
Furthermore, same treatments for different diseases,
another feature of CHM prescription, could be found
when comparing the prescription patterns among PMS,
primary dysmenorrhea and menopausal syndrome [20].
For example, JWXYS was also commonly used for mood
disorder in menopausal women [24] and DGSYS was
frequently used for primary dysmenorrhea and PMS [20].
This concept is quite different from western medicine
which often treats PMS after excluding other diagnoses
such as dysmenorrhea. Therefore, the treatment principle
considerably differs: analgesia for primary dysmenorrhea
and mood modifying for PMS. On TCM’s viewpoint, pre-
scriptions are made not only according to “disease” but
also TCM syndrome, “zheng”, and therefore it is not
uncommon to prescribe same formula to various diseases
if the same TCM syndrome is diagnosed [54].
“Qi stagnation and blood stasis” seemed the most
prevalent TCM syndrome for PMS. Although it was not
feasible to perform detailed analysis on TCM syndrome
of PMS since TCM syndrome was not recorded in the
NHIRD, the distribution of TCM syndrome could be
shown when summarizing the indications of commonly
used CHM [21,55]. Ten out of top 15 commonly used
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stasis” (Tables 1 and 2) and JWXYS is effective in affective
disorder caused by liver qi stagnation syndrome [56]. Qi
stagnation usually represented lesion distension or pain
due to impeded qi circulation and mood disorders, such
as depression or anxiety and depression was highly associ-
ated with liver qi stagnation [57]. Further, severe qi stagna-
tion may obstruct blood flow to cause blood stasis, but
blood stasis may aggravate qi stagnation conversely. This
TCM syndrome and pathogenesis reflected the concept
about PMS: mood disorders (qi stagnation) and menstrual
discomfort (blood stasis) are highly related. For this rea-
son, regulation on menstrual cycle is needed to treat PMS
for TCM doctors and that is why many CHM other than
JWXYS are added into one prescription for PMS.
This study explored the core formula, JWXYS, and
important combinations of CHM for PMS. This result
is especially crucial in searching for candidates that
are suitable for clinical or bench studies for PMS since
CHM prescriptions are usually different from textbooks
themselves [58]. The merit of this study is that the subject
selection is done from a nationwide database and thus
possible selection and referral bias can be eliminated.
Nonetheless, there are a number of limitations to con-
sider. First, the counts of prescriptions for PMS might be
underestimated since only visits with a single diagnosis of
PMS were used to identify the study population in this
study. Nevertheless, it is believed that the use of a single
diagnosis is helpful in eliminating unnecessary bias, espe-
cially when PMS is a syndrome with various presentations
and the impact from co-morbidities may be considerable.
Second, the validity of ICD-9 code for the diagnosis of
PMS should be considered. In Taiwan, the first diagnosis
code of each ambulatory visit represents the main reason
for the visit. As physicians and institutions are penalized
for fraudulent coding, monthly internal monitoring
are usually performed to validate diagnoses. This internal
monitoring theoretically improves the accuracy of the
database. Therefore, we believe the diagnostic codes are
specific and the registration bias can be minimized. Third,
the efficacy of therapies was not determined in this study.
Despite the fact that the nationwide database contains
large amounts of prescription data, there are no data on
PMS severities, laboratory or image examinations since
these data are not required in the electronic medical
records. Consequently, the effectiveness of CHM for PMS
is unable to be assessed by using this database.
Conclusions
The high prevalence and role of the core treatment
JWXYS for PMS is shown in this study. Also, the combi-
nations of CHM with JWXYS, such as Cyperus rotundus
L. and Leonurus heterophyllus Sweet, demonstrate the
potential effectiveness of anti-oxidant agents on PMS.Based on these results, further studies about CHM for
PMS are warranted both in bench research and clinical
trials to examine the effectiveness of these therapies.
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